These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 423213)

  • 1. Inhibition of gastric acid secretion by 1,8-naphthyridin-2(1H)-ones.
    Bolhofer WA; Hoffman JM; Habecker CN; Pietruszkiewicz AM; Cragoe EJ; Torchiana ML
    J Med Chem; 1979 Mar; 22(3):301-6. PubMed ID: 423213
    [No Abstract]   [Full Text] [Related]  

  • 2. Antivertigo agents. II. Structure-activity relationships of 6-substituted 5,6,7,8-tetrahydro-1,6-naphthyridines.
    Shiozawa A; Ichikawa Y; Ishikawa M; Kogo Y; Kurashige S; Miyazaki H; Yamanaka H; Sakamoto T
    Chem Pharm Bull (Tokyo); 1984 Mar; 32(3):995-1005. PubMed ID: 6744495
    [No Abstract]   [Full Text] [Related]  

  • 3. A benzimidazole derivative (7110 MD) with gastric antisecretory and antiulcer activity.
    Dorme N; Raynaud G
    J Pharm Pharmacol; 1976 Oct; 28(10):788-9. PubMed ID: 10381
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental antiulcer drugs. 2. 2-Substituted 2,4,5,6-tetrahydro-1,3,4,6,6-pentamethylcyclopenta[c]pyrrole-4-carboxamides.
    Oesterlin R; Bell MR; McGarry RH; Hlavac AG; Bradford JC; Rozitis J
    J Med Chem; 1977 Aug; 20(8):1068-71. PubMed ID: 894677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of gastric acid secretion in the rat by synthetic prostaglandin analogues.
    Lippmann W
    Ann N Y Acad Sci; 1971 Apr; 180():332-5. PubMed ID: 5286101
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiallergy agents. 1. Substituted 1,8-naphthyridin-2(1H)-ones as inhibitors of SRS-A release.
    Sherlock MH; Kaminski JJ; Tom WC; Lee JF; Wong SC; Kreutner W; Bryant RW; McPhail AT
    J Med Chem; 1988 Nov; 31(11):2108-21. PubMed ID: 2903244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings: 3-(4(5)-imidazolyl) propylguanidine (SK&F 91486) - a partial agonist at histamine H2-receptors.
    Parsons ME; Blakemore RC; Durant GJ; Ganellin CR; Rasmussen AC
    Agents Actions; 1975 Dec; 5(5):464. PubMed ID: 1220549
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacological effects of suriclone and its main metabolites].
    Morishita H; Kushiku K; Mathuki J; Tokunaga T; Inoue T; Mori R; Furukawa T
    Igaku Kenkyu; 1986 Mar; 56(1):35-50. PubMed ID: 3727901
    [No Abstract]   [Full Text] [Related]  

  • 9. [Syntheses of nitrogen-containing heterocyclic compounds. XLIV. Syntheses of 5-substituted 1,6-naphthyridine derivatives using the Reissert compound of 1,6-naphthyridine (author's transl)].
    Hamada Y; Shigemura K
    Yakugaku Zasshi; 1979 Dec; 99(12):1225-8. PubMed ID: 544763
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel cAMP PDE III inhibitors: 1,6-naphthyridin-2(1H)-ones.
    Singh B; Lesher GY; Pluncket KC; Pagani ED; Bode DC; Bentley RG; Connell MJ; Hamel LT; Silver PJ
    J Med Chem; 1992 Dec; 35(26):4858-65. PubMed ID: 1336055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity relationships of 7-substituted 3-(2, 6-dichlorophenyl)-1,6-naphthyridin-2(1H)-ones as selective inhibitors of pp60(c-src).
    Thompson AM; Rewcastle GW; Boushelle SL; Hartl BG; Kraker AJ; Lu GH; Batley BL; Panek RL; Showalter HD; Denny WA
    J Med Chem; 2000 Aug; 43(16):3134-47. PubMed ID: 10956222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Mercaptoacetamidines as gastric antisecretory agents.
    Bolhofer WA; Habecker CN; Pietruszkiewicz AM; Torchiana ML; Jacoby HI; Stone CA
    J Med Chem; 1979 Mar; 22(3):295-301. PubMed ID: 423212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New bronchodilators. 3. Imidazo[4,5-c][1,8]naphthyridin-4(5H)-ones.
    Suzuki F; Kuroda T; Kawakita T; Manabe H; Kitamura S; Ohmori K; Ichimura M; Kase H; Ichikawa S
    J Med Chem; 1992 Dec; 35(26):4866-74. PubMed ID: 1479586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Oxo-1,8-naphthyridine-3-carboxylic acid derivatives with potent gastric antisecretory properties.
    Santilli AA; Scotese AC; Bauer RF; Bell SC
    J Med Chem; 1987 Dec; 30(12):2270-7. PubMed ID: 3681897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors. Part 3: In vitro evaluation of 1,3,4,5-tetrahydro-benzo[c][1,6]- and [c][1,7]-naphthyridin-6-ones.
    Ferraris D; Ficco RP; Pahutski T; Lautar S; Huang S; Zhang J; Kalish V
    Bioorg Med Chem Lett; 2003 Aug; 13(15):2513-8. PubMed ID: 12852955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental antiulcer drugs. 1. Indole-1-alkanamides and pyrrole-1-alkanamides.
    Bell MR; Zalay AW; Oesterlin R; Clemans SD; Dumas DJ; Bradford JC; Rozitis J
    J Med Chem; 1977 Apr; 20(4):537-40. PubMed ID: 850239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and histamine H2-antagonist activity of 4-quinazolinone derivatives.
    Ogawa N; Yoshida T; Aratani T; Koshinaka E; Kato H; Ito Y
    Chem Pharm Bull (Tokyo); 1988 Aug; 36(8):2955-67. PubMed ID: 2907306
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and biological activity of carboxyl-terminus modified prostaglandin analogues.
    Schaaf TK; Hess HJ
    J Med Chem; 1979 Nov; 22(11):1340-6. PubMed ID: 533881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,8-naphthyridine derivatives: synthesis and pharmacological evaluation of beta-receptor blocking activity.
    Tonetti I; Bertini D; Ferrarini PI; Livi O
    Farmaco Sci; 1976 Mar; 31(3):175-82. PubMed ID: 3435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of (-)-isoprenaline and (+/-)-salbutamol on pepsinogen and acid secretion in the dog.
    Daly MJ; Stables R
    Br J Pharmacol; 1977 Feb; 59(2):323-5. PubMed ID: 837019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.